The DCTU conducts research studies that evaluate and monitor the safety and efficacy of new treatments for various dermatologic conditions in children and adults. Our particular interests are acne, psoriasis, onychomycosis, atopic dermatitis (eczema), epidermolysis bullosa, hidradenitis suppurativa, and pemphigus vulgaris. The DCTU collaborates with other UNC investigators on their melanoma and basal cell carcinoma clinical trials.
Clinical Trials
UNC Dermatology Clinical Trials Unit
Clinical Trials Currently Recruiting Patients
Dermatology Research Registry
If you are interested in possibly participating in any of our current or future research studies, please sign up for our Dermatology Research Registry online at: https://studypages.com/uncderm
Your information will be kept confidential and will only be used to contact you about potential research studies. Your information will not be shared.
Alopecia Areata Oral Tablet Study
Requirements: Patients are 18-60 years old if male or 18-70 years old if female with diagnosis of Alopecia Areata. Additional treatments other than the study medication are not permitted during the study period.
Duration: 104 weeks (approximately 2 years)
Incentive: Subject compensation and travel assistance may be available. Study treatment, study related exams, and lab tests will be provided at no cost.
Sponsor: Eli Lilly
For more information on this study please contact us:
Email:
Phone:
Donna Culton, MD, PhD
Associate Director
Special Interests:
Autoimmune Disorders
Complex Medical Dermatology
Oral Mucosal Disorders
Erika Hanami
Project Manager
